These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Iontophoretic drug delivery system: a review. Semalty A; Semalty M; Singh R; Saraf SK; Saraf S Technol Health Care; 2007; 15(4):237-45. PubMed ID: 17673833 [TBL] [Abstract][Full Text] [Related]
43. Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugs. Wang R; Bian Q; Xu Y; Xu D; Gao J Int J Pharm; 2021 Jun; 602():120598. PubMed ID: 33862129 [TBL] [Abstract][Full Text] [Related]
44. Microneedles for transdermal drug delivery. Prausnitz MR Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747 [TBL] [Abstract][Full Text] [Related]
45. [Transdermal drug delivery systems]. Foco A; Hadziabdić J; Becić F Med Arh; 2004; 58(4):230-4. PubMed ID: 15526592 [TBL] [Abstract][Full Text] [Related]
46. Vesicles as tools for the modulation of skin permeability. Dubey V; Mishra D; Nahar M; Jain NK Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662 [TBL] [Abstract][Full Text] [Related]
47. Modeling the human skin barrier--towards a better understanding of dermal absorption. Jepps OG; Dancik Y; Anissimov YG; Roberts MS Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516 [TBL] [Abstract][Full Text] [Related]
48. Discovery of transdermal penetration enhancers by high-throughput screening. Karande P; Jain A; Mitragotri S Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682 [TBL] [Abstract][Full Text] [Related]
49. Transdermal drug delivery systems: skin perturbation devices. Brown MB; Traynor MJ; Martin GP; Akomeah FK Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965 [TBL] [Abstract][Full Text] [Related]
50. Current Updates in Transdermal Therapeutic Systems and Their Role in Neurological Disorders. Yadav N; Mittal A; Ali J; Sahoo J Curr Protein Pept Sci; 2021; 22(6):458-469. PubMed ID: 33183199 [TBL] [Abstract][Full Text] [Related]
51. Transdermal delivery and the premature neonate. Barrett DA; Rutter N Crit Rev Ther Drug Carrier Syst; 1994; 11(1):1-30. PubMed ID: 7704917 [TBL] [Abstract][Full Text] [Related]
52. Vesicular carriers for dermal drug delivery. Sinico C; Fadda AM Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979 [TBL] [Abstract][Full Text] [Related]
53. Use of transdermal drug formulations in the elderly. Kaestli LZ; Wasilewski-Rasca AF; Bonnabry P; Vogt-Ferrier N Drugs Aging; 2008; 25(4):269-80. PubMed ID: 18361538 [TBL] [Abstract][Full Text] [Related]
55. [Therapeutic systems and drug delivery. 3. Transdermal therapeutic systems]. Davila D; Karleusa-Simanović A; Davila T Lijec Vjesn; 1990; 112(7-8):235-43. PubMed ID: 2292898 [TBL] [Abstract][Full Text] [Related]
56. Identifying present challenges to reliable future transdermal drug delivery products. Giannos SA Ther Deliv; 2015; 6(9):1033-41. PubMed ID: 26419262 [TBL] [Abstract][Full Text] [Related]
57. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Hearnden V; Sankar V; Hull K; Juras DV; Greenberg M; Kerr AR; Lockhart PB; Patton LL; Porter S; Thornhill MH Adv Drug Deliv Rev; 2012 Jan; 64(1):16-28. PubMed ID: 21371513 [TBL] [Abstract][Full Text] [Related]
58. Using controlled laser-microporation to increase transdermal delivery of prednisone. Yu J; Bachhav YG; Summer S; Heinrich A; Bragagna T; Böhler C; Kalia YN J Control Release; 2010 Nov; 148(1):e71-3. PubMed ID: 21529638 [No Abstract] [Full Text] [Related]
59. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications. Bachhav YG; Heinrich A; Kalia YN Eur J Pharm Biopharm; 2011 Aug; 78(3):408-14. PubMed ID: 21397689 [TBL] [Abstract][Full Text] [Related]